Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
252.15
0.00 (0.00%)
Jul 3, 2025, 4:00 PM EDT - Market closed
Bio-Rad Laboratories Market Cap
Bio-Rad Laboratories has a market cap or net worth of $6.84 billion as of July 3, 2025. Its market cap has decreased by -18.58% in one year.
Market Cap
6.84B
Enterprise Value
6.55B
1-Year Change
-18.58%
Ranking
Category
Stock Price
$252.15
Market Cap Chart
Since July 6, 2020, Bio-Rad Laboratories's market cap has decreased from $13.83B to $6.84B, a decrease of -50.57%. That is a compound annual growth rate of -13.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 7.03B | -23.58% |
| Dec 31, 2024 | 9.20B | -1.07% |
| Dec 29, 2023 | 9.30B | -25.52% |
| Dec 30, 2022 | 12.48B | -44.81% |
| Dec 31, 2021 | 22.62B | 30.09% |
| Dec 31, 2020 | 17.39B | 25.67% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.55B |
| Johnson & Johnson | 375.15B |
| AbbVie | 335.60B |
| Novo Nordisk | 306.99B |
| UnitedHealth Group | 295.85B |
| Novartis AG | 242.04B |
| Abbott Laboratories | 237.07B |
| AstraZeneca | 221.11B |